Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
UTHR holding history
United Therapeutics Corp in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −307,314−100.0% | Sold out | Holders |
| Q3 2023 | 307,314 | $69.4M | 4.7% | +68,926+28.9% | Added | Holders |
| Q2 2023 | 238,388 | $52.6M | 4.3% | +26,496+12.5% | Added | Holders |
| Q1 2023 | 211,892 | $47.5M | 4.5% | +63,000+42.3% | Added | Holders |
| Q4 2022 | 148,892 | $41.4M | 4.9% | +8,331+5.9% | Added | Holders |
| Q3 2022 | 140,561 | $29.4M | 4.1% | −22,505−13.8% | Reduced | Holders |
| Q2 2022 | 163,066 | $38.4M | 7.7% | +87,431+115.6% | Added | Holders |
| Q1 2022 | 75,635 | $13.6M | 3.6% | +75,635 | New | Holders |